BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8578048)

  • 41. [Myelodysplastic syndromes].
    Garandeau C; Pautas E; Andreux M; Andreux J; Gaussem P; Siguret V
    Ann Biol Clin (Paris); 2000; 58(4):405-16. PubMed ID: 10932040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
    Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
    Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The treatment of myelodysplastic syndromes.
    Spriggs DR; Stone RM; Kufe DW
    Clin Haematol; 1986 Nov; 15(4):1081-107. PubMed ID: 3552348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Myelodysplastic diseases in childhood].
    Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
    Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.
    Garcia-Manero G
    Am J Hematol; 2011 Jun; 86(6):490-8. PubMed ID: 21594886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myelodysplastic syndromes: a practical approach to diagnosis and treatment.
    Barzi A; Sekeres MA
    Cleve Clin J Med; 2010 Jan; 77(1):37-44. PubMed ID: 20048028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experience in pediatric myelodysplastic syndromes.
    Gadner H; Haas OA
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):655-72. PubMed ID: 1613011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Myelodysplastic syndromes. The epidemiological and etiological aspects].
    Aul C; Gattermann N; Germing U; Runde V; Heyll A
    Dtsch Med Wochenschr; 1992 Aug; 117(33):1223-31. PubMed ID: 1499520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Myelodysplastic syndromes--an overview for the practitioner].
    Solenthaler M; Tobler A
    Ther Umsch; 2004 Feb; 61(2):117-24. PubMed ID: 15018394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The myelodysplastic syndromes: diagnosis and treatment.
    Steensma DP; Bennett JM
    Mayo Clin Proc; 2006 Jan; 81(1):104-30. PubMed ID: 16438486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current management of myelodysplastic syndromes].
    Vey N; Charbonnier A
    Rev Prat; 2010 Dec; 60(10):1416-9. PubMed ID: 21425543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management.
    Montalban-Bravo G; Garcia-Manero G
    Am J Hematol; 2018 Jan; 93(1):129-147. PubMed ID: 29214694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preleukaemia and myelodysplastic syndromes today.
    Jacobs A
    Recenti Prog Med; 1989 Oct; 80(10):501-7. PubMed ID: 2690216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.
    Dinmohamed AG; Visser O; van Norden Y; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
    Eur J Cancer; 2014 Mar; 50(5):1004-12. PubMed ID: 24388662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical course of myelodysplastic syndromes.
    Ganser A; Hoelzer D
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):607-18. PubMed ID: 1613009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of myelodysplastic syndromes with cytokines].
    Tohyama K; Ueda T; Tsutani H; Wano Y; Nakamura T
    Rinsho Ketsueki; 1993 Mar; 34(3):277-82. PubMed ID: 8479078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myelodysplastic syndromes: a review for nurses.
    Cain J; Hood-Barnes J; Spangler J
    Oncol Nurs Forum; 1991; 18(1):113-7. PubMed ID: 2003103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis and therapy of myelodysplastic syndromes in Germany: a retrospective multicenter analysis.
    Gattermann N; Kündgen A; Kellermann L; Zeffel M; Paessens B; Germing U
    Onkologie; 2012; 35(6):350-6. PubMed ID: 22722455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes.
    Germing U; Strupp C; Giagounidis A; Haas R; Gattermann N; Starke C; Aul C
    Leuk Res; 2012 Jun; 36(6):727-34. PubMed ID: 22421409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of myelodysplastic syndromes].
    Aul C; Heyll A; Gattermann N; Schneider W
    Dtsch Med Wochenschr; 1987 Feb; 112(8):309-13. PubMed ID: 3469067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.